Stock warrant tracker
Every outstanding warrant series recorded in a Signal8 dilution snapshot, one row per series: the shares it can be exercised into, the exercise price (strike), the expiry date, whether the price can reset after a later financing, and the SEC filing each figure was read from. Exercise prices and share counts are restated for every stock split since the filing, so they compare directly with the current share price.
5,325 warrant series at 1,053 companies. 777 in the money, 58 expiring in the next 30 days, 39 waiting on a stockholder vote or other stated condition, 0 becoming exercisable in the next 30 days.
Outstanding warrants
| Series | Shares | Exercise price | Last price | Vs strike | Expiry | Exercisable | Terms | Overhang | Source | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CP BF Common Stock Purchase Warrant (Sept 2024) | $0.0727 | $4.9M | 424B4, Nov 6, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| Evergreen Common Warrant (Sept 2026 private placement) | $0.0727 | $4.9M | 10-Q, Nov 16, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| GEM Warrant | $0.0727 | $4.9M | 10-Q, Nov 16, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| May 2024 Best Efforts Offering Common Warrants | $0.0727 | $4.9M | 424B4, Nov 6, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| May 2024 Best Efforts Offering Placement Agent Warrants | $0.0727 | $4.9M | 424B4, Nov 6, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| November 2026 Common Warrants (Aegis unit offering) | $0.0727 | $4.9M | 10-Q, Nov 16, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| November 2026 Pre-Funded Warrants (Aegis unit offering) | $0.0727 | $4.9M | 10-Q, Nov 16, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| PIPE Placement Agent Warrants (listed as June 2025 PIPE) | $0.0727 | $4.9M | 424B4, Nov 6, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| Public Warrants (7GC IPO) | $0.0727 | $4.9M | 10-Q, Nov 16, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| Series A Warrants (Sept 2024 private placement) | $0.0727 | $4.9M | 424B4, Nov 6, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| Series B Warrants (Sept 2024 private placement) | $0.0727 | $4.9M | 424B4, Nov 6, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| Warrants outstanding as of September 30, 2026 (aggregate, per Note 11 table) | $2.76 | $4.9M | 10-Q, Nov 16, 2026Dilution tabAs of Nov 16, 2026 | ||||||||
| AIL Warrant (issued with $2,450,000 convertible promissory note, March 26, 2026) | $0.4900 | $4.9M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Alset Inc. Warrants (issued with $1,000,000 convertible note, June 23, 2026) | $0.4900 | $4.9M | 10-Q, Aug 14, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| SPA Initial Warrants (Anson purchasers) and Maxim placement-agent warrant — registered aggregate | $0.0865 | $4.9M | F-3/A, Aug 5, 2025Dilution tabAs of Nov 8, 2026 | ||||||||
| Warrants exercisable at $20.16 per share (expiring April 2028) | $0.3640 | $4.9M | 10-Q, Aug 13, 2026Dilution tabAs of Nov 4, 2026 | ||||||||
| Perceptive Fund III Warrant Certificate No. 4 (August 2025, Perceptive Credit Holdings III, LP) | $6.01 | $4.9M | 6-K EX-99.6, Nov 12, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| Perceptive Warrant Certificate No. 1 (Perceptive Credit Holdings III, LP) | $6.01 | $4.9M | 6-K EX-99.2, Nov 12, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| Perceptive Warrant Certificate No. 2 (Perceptive Credit Holdings III, LP) | $6.01 | $4.9M | 6-K EX-99.3, Nov 12, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| Perceptive Warrant Certificate No. 3 (Perceptive Credit Holdings III, LP) | $6.01 | $4.9M | 6-K EX-99.4, Nov 12, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| Perceptive Warrant Certificate No. 4 (Perceptive Credit Holdings II, LP) | $6.01 | $4.9M | 6-K EX-99.5, Nov 12, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| Series H Placement Agent Warrants | $0.4884 | $4.9M | 10-Q, Aug 14, 2026Dilution tabAs of Oct 21, 2026 | ||||||||
| Series H Warrants (Investor) – First Closing | $0.4884 | $4.9M | 10-Q, Aug 14, 2026Dilution tabAs of Oct 21, 2026 | ||||||||
| Series H Warrants (Investor) – Second Closing | $0.4884 | $4.9M | 10-Q, Aug 14, 2026Dilution tabAs of Oct 21, 2026 | ||||||||
| January 2024 Common Warrants ($112.50) | $1.73 | $4.8M | 10-K, Mar 18, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| January 2024 Placement Agent Warrants ($140.63) | $1.73 | $4.8M | 10-K, Mar 18, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| January 2025 Series A Warrants ($16.25) | $1.73 | $4.8M | 10-K, Mar 18, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| January 2025 Series B Warrants ($16.25) | $1.73 | $4.8M | 10-K, Mar 18, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| June 2025 Common Warrants ($6.25) | $1.73 | $4.8M | 10-K, Mar 18, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| June 2025 Placement Agent Warrants ($7.81) | $1.73 | $4.8M | 10-K, Mar 18, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| June 2026 PIPE Warrants (Class A share purchase warrants, $1.28 initial exercise price) | $5.23 | $4.8M | 6-K, Jun 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| September 2026 Over-Allotment Warrants ($2.75) | $5.23 | $4.8M | 6-K, Sep 25, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| Class A Common Stock Purchase Warrants (July 2026 concurrent private placement) | $0.2666 | $4.8M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| Class B Common Stock Purchase Warrants (July 2026 concurrent private placement) | $0.2666 | $4.8M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| Consultant warrant (September 17, 2021 referral and support services agreement), vested portion | $0.2666 | $4.8M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| Placement Agent Warrants (Ladenburg Thalmann, July 2026 offerings) | $0.2666 | $4.8M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| 2025 RDO Warrants (RDO Investor Warrants and RDO PA Warrants, May 2025) — repriced Investor Warrants | $0.3799 | $4.8M | DEF 14A, Oct 8, 2026Dilution tabAs of Nov 16, 2026 | ||||||||
| Bridge Extension Warrants (June 24, 2025, Replacement Notes) — repriced Investor Warrants | $0.3799 | $4.8M | DEF 14A, Oct 8, 2026Dilution tabAs of Nov 16, 2026 | ||||||||
| Bridge Extension Warrants held by Insiders (June 24, 2025) — not repriced | $0.3799 | $4.8M | DEF 14A, Oct 8, 2026Dilution tabAs of Nov 16, 2026 | ||||||||
| Bridge Financing Warrants (non-Insider investors and Placement Agent, March 31, 2025) — repriced Investor Warrants | $0.3799 | $4.8M | DEF 14A, Oct 8, 2026Dilution tabAs of Nov 16, 2026 | ||||||||
| Bridge Investor Warrants held by Insiders (March 31, 2025) — not repriced | $0.3799 | $4.8M | DEF 14A, Oct 8, 2026Dilution tabAs of Nov 16, 2026 | ||||||||
| January 2026 Warrants (promissory note inducement) — repriced Investor Warrants | $0.3799 | $4.8M | DEF 14A, Oct 8, 2026Dilution tabAs of Nov 16, 2026 | ||||||||
| Napo Therapeutics Pre-Funded Warrant (Joshua Mailman, September 15, 2026) | $0.3799 | $4.8M | 10-Q, Nov 16, 2026Dilution tabAs of Nov 16, 2026 | ||||||||
| Series O dividend conversion shares deliverable upon exercise of Series O Eligible Warrants | $0.3799 | $4.8M | 10-Q, Nov 16, 2026Dilution tabAs of Nov 16, 2026 | ||||||||
| Series R dividend conversion shares deliverable upon exercise of the Investor Warrants | $0.3799 | $4.8M | DEF 14A, Oct 8, 2026Dilution tabAs of Nov 16, 2026 | ||||||||
| Underwriter warrants issued to D. Boral Capital LLC (formerly EF Hutton LLC) and affiliates in connection with the IPO | $1.67 | $4.7M | 10-K, Sep 28, 2026Dilution tabAs of Nov 16, 2026 | ||||||||
| IPO warrants (RVSNW, April 2022) | $2.04 | $4.7M | 20-F, Mar 31, 2026Dilution tabAs of Oct 3, 2026 | ||||||||
| January 2024 Facility Warrant (L.I.A. Pure Capital) | $2.04 | $4.7M | 6-K EX-99.2, Aug 26, 2026Dilution tabAs of Oct 3, 2026 | ||||||||
| KB Private Placement warrants (Knorr-Bremse, June 2023) | $2.04 | $4.7M | 20-F, Mar 31, 2026Dilution tabAs of Oct 3, 2026 | ||||||||
| SAFE conversion warrants (April 2022) | $2.04 | $4.7M | 20-F, Mar 31, 2026Dilution tabAs of Oct 3, 2026 |
PARAParabolic Technologies, Inc. Class A$0.0727Last price
CP BF Common Stock Purchase Warrant (Sept 2024)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.9M
PARAParabolic Technologies, Inc. Class A$0.0727Last price
Evergreen Common Warrant (Sept 2026 private placement)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.9M
PARAParabolic Technologies, Inc. Class A$0.0727Last price
GEM Warrant
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.9M
PARAParabolic Technologies, Inc. Class A$0.0727Last price
May 2024 Best Efforts Offering Common Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.9M
PARAParabolic Technologies, Inc. Class A$0.0727Last price
May 2024 Best Efforts Offering Placement Agent Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.9M
PARAParabolic Technologies, Inc. Class A$0.0727Last price
November 2026 Common Warrants (Aegis unit offering)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.9M
PARAParabolic Technologies, Inc. Class A$0.0727Last price
November 2026 Pre-Funded Warrants (Aegis unit offering)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.9M
PARAParabolic Technologies, Inc. Class A$0.0727Last price
PIPE Placement Agent Warrants (listed as June 2025 PIPE)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.9M
PARAParabolic Technologies, Inc. Class A$0.0727Last price
Public Warrants (7GC IPO)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.9M
PARAParabolic Technologies, Inc. Class A$0.0727Last price
Series A Warrants (Sept 2024 private placement)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.9M
PARAParabolic Technologies, Inc. Class A$0.0727Last price
Series B Warrants (Sept 2024 private placement)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.9M
SCNXScienture Holdings, Inc.$2.76Last price
Warrants outstanding as of September 30, 2026 (aggregate, per Note 11 table)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.9M
DSSDSS, Inc.$0.4900Last price
AIL Warrant (issued with $2,450,000 convertible promissory note, March 26, 2026)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.9M
DSSDSS, Inc.$0.4900Last price
Alset Inc. Warrants (issued with $1,000,000 convertible note, June 23, 2026)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.9M
DDCDDC Enterprise Limited$0.0865Last price
SPA Initial Warrants (Anson purchasers) and Maxim placement-agent warrant — registered aggregate
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.9M
YCBDcbdMD, Inc.$0.3640Last price
Warrants exercisable at $20.16 per share (expiring April 2028)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.9M
TRIBTrinity Biotech plc$6.01Last price
Perceptive Fund III Warrant Certificate No. 4 (August 2025, Perceptive Credit Holdings III, LP)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.9M
TRIBTrinity Biotech plc$6.01Last price
Perceptive Warrant Certificate No. 1 (Perceptive Credit Holdings III, LP)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.9M
TRIBTrinity Biotech plc$6.01Last price
Perceptive Warrant Certificate No. 2 (Perceptive Credit Holdings III, LP)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.9M
TRIBTrinity Biotech plc$6.01Last price
Perceptive Warrant Certificate No. 3 (Perceptive Credit Holdings III, LP)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.9M
TRIBTrinity Biotech plc$6.01Last price
Perceptive Warrant Certificate No. 4 (Perceptive Credit Holdings II, LP)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.9M
XWELXWELL, Inc.$0.4884Last price
Series H Placement Agent Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.9M
XWELXWELL, Inc.$0.4884Last price
Series H Warrants (Investor) – First Closing
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.9M
XWELXWELL, Inc.$0.4884Last price
Series H Warrants (Investor) – Second Closing
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.9M
PCSAProcessa Pharmaceuticals, Inc.$1.73Last price
January 2024 Common Warrants ($112.50)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.8M
PCSAProcessa Pharmaceuticals, Inc.$1.73Last price
January 2024 Placement Agent Warrants ($140.63)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.8M
PCSAProcessa Pharmaceuticals, Inc.$1.73Last price
January 2025 Series A Warrants ($16.25)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.8M
PCSAProcessa Pharmaceuticals, Inc.$1.73Last price
January 2025 Series B Warrants ($16.25)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.8M
PCSAProcessa Pharmaceuticals, Inc.$1.73Last price
June 2025 Common Warrants ($6.25)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.8M
PCSAProcessa Pharmaceuticals, Inc.$1.73Last price
June 2025 Placement Agent Warrants ($7.81)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.8M
RETOReTo Eco-Solutions, Inc. Class A Shares$5.23Last price
June 2026 PIPE Warrants (Class A share purchase warrants, $1.28 initial exercise price)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.8M
RETOReTo Eco-Solutions, Inc. Class A Shares$5.23Last price
September 2026 Over-Allotment Warrants ($2.75)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.8M
INUVInuvo, Inc.$0.2666Last price
Class A Common Stock Purchase Warrants (July 2026 concurrent private placement)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.8M
INUVInuvo, Inc.$0.2666Last price
Class B Common Stock Purchase Warrants (July 2026 concurrent private placement)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.8M
INUVInuvo, Inc.$0.2666Last price
Consultant warrant (September 17, 2021 referral and support services agreement), vested portion
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.8M
INUVInuvo, Inc.$0.2666Last price
Placement Agent Warrants (Ladenburg Thalmann, July 2026 offerings)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.8M
JAGXJaguar Health, Inc.$0.3799Last price
2025 RDO Warrants (RDO Investor Warrants and RDO PA Warrants, May 2025) — repriced Investor Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.8M
JAGXJaguar Health, Inc.$0.3799Last price
Bridge Extension Warrants (June 24, 2025, Replacement Notes) — repriced Investor Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.8M
JAGXJaguar Health, Inc.$0.3799Last price
Bridge Extension Warrants held by Insiders (June 24, 2025) — not repriced
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.8M
JAGXJaguar Health, Inc.$0.3799Last price
Bridge Financing Warrants (non-Insider investors and Placement Agent, March 31, 2025) — repriced Investor Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.8M
JAGXJaguar Health, Inc.$0.3799Last price
Bridge Investor Warrants held by Insiders (March 31, 2025) — not repriced
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.8M
JAGXJaguar Health, Inc.$0.3799Last price
January 2026 Warrants (promissory note inducement) — repriced Investor Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.8M
JAGXJaguar Health, Inc.$0.3799Last price
Napo Therapeutics Pre-Funded Warrant (Joshua Mailman, September 15, 2026)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.8M
JAGXJaguar Health, Inc.$0.3799Last price
Series O dividend conversion shares deliverable upon exercise of Series O Eligible Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.8M
JAGXJaguar Health, Inc.$0.3799Last price
Series R dividend conversion shares deliverable upon exercise of the Investor Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.8M
BTOCArmlogi Holding Corp. common stock$1.67Last price
Underwriter warrants issued to D. Boral Capital LLC (formerly EF Hutton LLC) and affiliates in connection with the IPO
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.7M
RVSNRail Vision Ltd. Ordinary Share$2.04Last price
IPO warrants (RVSNW, April 2022)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.7M
RVSNRail Vision Ltd. Ordinary Share$2.04Last price
January 2024 Facility Warrant (L.I.A. Pure Capital)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.7M
RVSNRail Vision Ltd. Ordinary Share$2.04Last price
KB Private Placement warrants (Knorr-Bremse, June 2023)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.7M
RVSNRail Vision Ltd. Ordinary Share$2.04Last price
SAFE conversion warrants (April 2022)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$4.7M
Source: SEC filings cited in each company’s dilution snapshot, compiled by Signal8, as of November 17, 2026.
Read from 2,066 dilution snapshots. 4,872 of 5,325 series state an exercise price and 3,364 an expiry date. 184 record when exercise begins; that count grows as companies are re-extracted. 623 series are left off because their figures could not be restated for a stock split. 19 companies and 0 series are held back pending review. Share counts, exercise prices, expiry dates and terms are included in Signal8 Pro. Not investment advice.
About this list
Most of the companies listed are small caps and penny stocks, where warrants are routinely issued with registered direct offerings, PIPEs and underwritten unit deals. When a warrant is exercised the company issues new shares, so the list is a record of shares that do not exist yet but can be issued.
Coverage is limited to the companies Signal8 has a dilution snapshot for. A company that is not listed may still have warrants outstanding, and a figure shown as Not stated was not found in the filings read, which is not a statement that it is zero.
The date a warrant first becomes exercisable is recorded only for companies extracted since Signal8 started reading it. Not recorded yet means the snapshot predates that field, not that the warrant is exercisable. Coverage grows as companies are re-extracted.
Frequently asked questions
- What is a stock warrant?
- A warrant gives its holder the right to buy new shares from the company at a fixed exercise price until an expiry date. When warrants are exercised the company issues new shares, which adds to the share count. Unlike an exchange-listed option, a warrant is issued by the company itself, usually alongside a financing.
- What does in the money mean for a warrant?
- A warrant is in the money when the current share price is above its exercise price, so exercising it costs less than buying the shares on the market. This page compares the last price with the exercise price after restating both for any stock split, and says No recent price when there is no price from the last 7 days.
- Which warrants are expiring soon?
- Each row shows the expiry date stated in the filing, and series that expire within 30 days are marked. A warrant that is not exercised by its expiry date lapses and no shares are issued for it. A row whose stated date has passed says so; the filing record does not show whether that series was exercised before it lapsed.
- What is a warrant exercise price reset or full ratchet?
- Some warrants lower their exercise price if the company later sells shares more cheaply. A full ratchet resets it to the new lower price; a weighted-average adjustment moves it part of the way; some warrants reset on a set date to a price tied to the market. A lower exercise price can also raise the number of shares the warrant covers. The Terms column shows the adjustment the filing describes.
- What is a pre-funded warrant?
- A pre-funded warrant is one where the buyer has already paid almost the whole price up front, leaving a nominal exercise price such as $0.0001 per share. It is in the money by construction, so this page marks it as such and does not rank it by distance from the strike.
- Why are exercise prices split-adjusted?
- Filings state exercise prices and share counts as of their filing date. After a reverse split a warrant covers fewer shares at a higher price. Signal8 restates both onto the current share basis; a series whose basis cannot be resolved is left off the page and counted under the table, rather than shown as filed.
- What is warrant overhang?
- Overhang is the number of shares the warrants can be exercised into, shown here as a percentage of shares outstanding, with both figures on the same split basis. Not measured means one of the two figures is missing.
- Where does the data come from and how often is it updated?
- Each row is read from the SEC filings cited in that company’s Signal8 dilution snapshot, and the source filing link on every row opens the document the figures were taken from. The list is rebuilt from the latest snapshots at least every 30 minutes, and each row shows the date of the snapshot it was read from.
Related
- PIPE tracker: private placements and registered directs
- Pending S-1 filings: offerings not yet effective
- Reverse split calendar
- Recently delisted stocks
- High dilution scanner
- Stock dilution checker
- Warrant overhang: how to count shares not issued yet
- Warrant price resets and ratchets explained
- Warrant inducements explained
- Warrants vs options
- How to read the Signal8 dilution tab
Not investment advice.